Our partners

AstraZeneca in Oncology

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company’s focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them antibiotics, antimalarials and cancer medicines. Roche has been recognised as the leading healthcare company in the Dow Jones Sustainability Indices for ten consecutive years.

Pfizer

One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer.
This motivates all of us at Pfizer and we share that goal with healthcare providers, patient advocates, caregivers, biopharma companies, and everyone living with cancer.
Together, we’ve made meaningful progress, but our work is far from finished. The millions of people living with cancer and the millions more who will receive a diagnosis are the reason we continue to work relentlessly to deliver on our purpose: breakthroughs that change patients’ lives.

Amgen

Established in 1991, Amgen Australia works to further the company’s global efforts to transform the promise of science and biotechnology into therapies that restore health and save lives. Hundreds of thousands of Australians use one of Amgen’s 18 products and thousands more have been enrolled in clinical studies that have helped deliver the next generation of innovative treatments. Amgen Australia is proud to support these patients and to contribute to the development of new therapies in partnership with Australia’s leading healthcare, academic, research, government and patient organisations.

Maurice Blackburn

For over 100 years, Maurice Blackburn has championed the rights of everyday Australians and been by the side of workers everywhere. As the Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) legal partner, Maurice Blackburn provides legal advice to members and your patients, ranging from:
• Asbestos, silica and other lung occupational diseases
• Superannuation and insurance claims
• Wills & Estates
• Workplace injuries
• Covid-19 contracted in the workplace

BMS (Bristol Myers Squibb)

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, haematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.